Red cell parameters in infant and children from the Arabian Peninsula

Lolowa A Al Mekaini1, Srdjan Denic2, Omar N Al Jabri3

  • 1Department of Pediatrics, United Arab Emirates University Al-Ain, UAE.

Insights

Alpha-plus thalassemia trait and iron deficiency anemia are common in Arabian children, affecting red blood cell parameters. These conditions present unique diagnostic challenges compared to European norms.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Genetics

Background:

  • Microcytosis in children is often caused by alpha-plus thalassemia trait and iron deficiency anemia.
  • These conditions pose a diagnostic challenge in Arabian populations.
  • Prevalence and red cell parameter effects require specific evaluation in this demographic.

Purpose of the Study:

  • To determine the prevalence of alpha-plus thalassemia trait and iron deficiency anemia in Arabian children.
  • To analyze the impact of these conditions on red cell parameters.
  • To compare findings with established European-based norms.

Main Methods:

  • Retrospective analysis of 28,457 children aged 1 day to 6 years.
  • Defined alpha-plus thalassemia trait by MCV <94 fL at birth.
  • Defined iron deficiency anemia by RDW >14.5%.

Main Results:

  • Prevalence of alpha-plus thalassemia trait was 15.7%.
  • Iron deficiency anemia peaked at 7 months (53%) and declined thereafter.
  • Physiological anemia nadirs observed at 2 months; subsequent Hb and MCV increases were coupled.
  • Third percentile MCV in children >3 months was significantly lower than European norms (≤64 fL).

Conclusions:

  • Alpha-plus thalassemia trait and iron deficiency anemia are highly prevalent in Arabian children.
  • Red cell indices in these children differ significantly from European-based standards.
  • Clinical interpretation of microcytic anemia requires careful consideration of local norms and these prevalent conditions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
317
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.7K